
This episode discusses the latest updates on Diffuse Large B-Cell Lymphoma, including new treatment options.
This week’s episode will be focusing on Diffuse Large B-Cell Lymphoma (DLBCL). We will go all the important details on this aggressive NHL which can be highly curable. We have some new changes since we last covered this topic in 2022 including a new category 1 option for advanced DLBCL
Explore listener stats, chart rankings, contacts and more on the Two Onc Docs podcast page.